Archive

Archive for January 15, 2008

101 ways to improve your health

101gwtiyll.jpg  This is an offer provided by eHealthSupplies.com

SPECIAL: FREE SHIPPING and  Signed By Dr. Eric Madrid (Creator of this Blog), author of Health Tip 49, “Health Benefits of Negative Ions”. Furthermore, when you order this book, you will get a FREE $20 Gift Certificate Coupon  when you purchase anything at eHealthSupplies.com101 Great Ways to Improve Your Health” is a compilation (SelfGrowth.com)of 101 proven strategies with reliable, tried-and-true ways to become a healthier person. ”101 Great Ways to Improve Your Health” is literally the “Who?s Who” of the top health experts in the world. Contributing authors you?ll be amazed to find Dr. Joseph Mercola (Mercola.com), Gary Craig, Dr. Marcus Laux, Dr. Susan Lark, Dr. Eric Madrid, Dr. Stephen Sinatra, Dr. Julian Whitaker (Whitaker Wellness Center) and many other leading health experts.  In total, there are 101 health experts, from both mainstream and alternative viewpoints, who give you the very best  in health recommendations. 

PART I: BETTER HEALTH THROUGH SELF IMPROVEMENT- Health Ideas: 1-11

  • Includes titles like: The Paradox of Forgiveness, Laugh Don’t Cry, Love your body, Love yourself

PART II:  DIET AND NUTRTITION- Health Ideas: Health Ideas: 12-26

  • Going Organic, Why the Big Fuss, Know your Good Fats, What’s in our Foods and much more.

PART III: ENERGY HEALING AND OTHER TECHNIQUES- Health Ideas:  27-38

PART IV:  FITNESS AND EXERCISE   Health Ideas: 39-46

PART V: HIDDEN HEALTH DANGERS Health Ideas: 47-57

  • Tip 49, “Health Benefits of Negative Ions”. Dr. Eric Madrid

PART VI: HOLISTIC HEALTH Health Ideas: 58-70

PART VII: PHYSICAL AND MENTAL DISORDERS AND PROBLEMS Health Ideas: 71-80

PART VIII: STRESS AND MENTAL  HEALTH Health Ideas: 81-91

PART: IX:  VITAMINS, MINERALS AND NUTRTIONAL SUPPLEMENTS  Health Ideas: 92-101

If you are concerned about your health, then you should get  this book. 

Zetia and Vytorin no better than generic meds… only costs more

Zetia  has been marketed to physicians by drug reps ever since it came out. The fact that there does not appear to be any benefit to patients is a big blow to the drug industry.   I have always been a cynical person so this study  does not surprise me.   Unfortunately, I think this information will cause physicians to  less  likely  trust and believe what a  drug rep has to share with them. 

I know they are doing their job and providing information given to them by their company but credibility is seriously becoming an issue with not only me but with doctors all over the country.   I recently posted an article about drug companies spending twice a much on advertising than research… perhaps this is the problem, they sell a product with millions spent  on advertising but have not done their research as thoroughly as they should have.

An interesting quote in the article was:

 “In a study of 720 patients funded by the manufacturers, Vytorin — a combination of the drugs simvastatin and ezetemibe — reduced levels of LDLs, the so-called bad cholesterol, by about 29% more than simvastatin alone. But it did not reduce the buildup of plaque in the coronary arteries — a key indicator of progression toward heart disease.”

If I did not know any better, this statement almost seems to contradict the cholesterol-> heart disease paradigm.  Other studies have shown benefits to reducing cholesterol, which is only one of many risk factors for heart disease. 

————— 

Study funded by firms that make the widely prescribed cholesterol blocker says it doesn’t help fight arterial plaque buildup

By Thomas H. Maugh II, Los Angeles Times Staff Writer
The heavily advertised drug Vytorin is no better than an inexpensive generic drug at blocking the damaging effects of high cholesterol levels, according to new data released by the drug’s manufacturers Monday.In a study of 720 patients funded by the manufacturers, Vytorin — a combination of the drugs simvastatin and ezetemibe — reduced levels of LDLs, the so-called bad cholesterol, by about 29% more than simvastatin alone. But it did not reduce the buildup of plaque in the coronary arteries — a key indicator of progression toward heart disease.The results indicated that the addition of ezetemibe — which blocks the absorption of cholesterol in the intestines and is the key component that has turned Vytorin into a multibillion-dollar blockbuster — produces no additional benefit.

“What a stunning reversal for this drug,” said Dr. Steven Nissen, a cardiologist at the Cleveland Clinic Foundation, who was not involved in the study. The new finding “suggests that Vytorin is simply . . . not useful. It should only be used as a last resort for patients who have failed every other drug…..Read the entire story here

Fish Oils help memory…

Anti-Alzheimer’s Mechanism In Omega-3 Fatty Acids Found

ScienceDaily (2008-01-02) — It’s good news that we are living longer, but bad news that the longer we live, the better our odds of developing late-onset Alzheimer’s disease. Researchers now report that omega-3 fatty acid docosahexaenoic acid, found in fish oil, increases the production of LR11, a protein that is found at reduced levels in Alzheimer’s patients and which is known to destroy the the “plaques” associated with the disease. … > read full article

Vitamin D Deficiency and Fall Risk

Vitamin D2 Supplements May Help Prevent Falls Among High-risk Older Women

ScienceDaily (2008-01-15) — Vitamin D2 supplements appear to reduce the risk of falls among women with a history of falling and low blood vitamin D levels living in sunny climates, especially during the winter, according to a new article. … > read full article

Resistant Superbug even worse than thought

MRSA MRSA, or Methicillin Resistant Staph Aureus  has become a major problem in communities throughout the USA.  I usually see 3-4 patients a week with MRSA infections. The patient usually comes in with what they think is a “spider bite” only to be diagnosed with MRSA.  Although hundreds have complained of spider bites, only 1 patient had ever seen the spider bite them- that person did not have MRSA.

I practice in  anytown, USA, located halfway between San Diego and Los Angeles.  MRSA is generally treated with a sulfa antibiotic called Septra or Bactrim (TMP-SMX).   In the last 5 years,  I have had one patient who was resistant to  not only the sulfa antibiotic but also to  vancomycin, a medicine usually given to patients in the hospital.

Vancomycin is considered to be  one of  the strongest antibiotics out there.  When Vancomycin does not work, a physician may prescribe Linezolid which is usally taken 2 times a day for 10-14 days. The cost  is about $75 per pill. A 10 day course will cost about $1500.00.

 ———-

(01-14) 14:11 PST SAN FRANCISCO– A new variety of staph bacteria, highly resistant to antibiotics and possibly transmitted by sexual contact, is spreading among gay men in San Francisco, Boston, New York and Los Angeles, researchers reported Monday.

The study released online by the journal Annals of Internal Medicine found the highest concentrations of infection by the drug-resistant bug in and around San Francisco’s Castro district and among patients who visit health clinics that treat HIV infections in gay men in San Francisco and Boston.

The culprit is a form of MRSA, or methicillin-resistant Staphylococcus aureus, a bug that was once confined to hospitalized patients but, since the late 1990s, has been circulating outside medical settings, afflicting anyone from injection-drug users to elementary school students. A strain called USA300 has been a leading cause of MRSA infection in this decade, and an exceptionally drug-resistant variant of it is now on the loose, researchers say.

The study estimated that 1 in 588 residents living within the Castro neighborhood 94114 ZIP code area is infected with that variant, which is resistant to six types of commonly used antibiotics. The risk of contracting this difficult-to-treat bug is 13 times greater for gay men than for the rest of the city’s population, researchers found.

“We probably had it here first, and now it is spreading elsewhere,” said Binh An Diep, a researcher at San Francisco General Hospital and lead author of the report. “This is a national problem, and San Francisco is at the epicenter.”

The germ typically causes boils and other skin and soft-tissue infections and, despite its resistance to some drugs, is still treatable by surgical drainage and several classes of antibiotics. What is unusual in this case is the high percentage of infections – up to 40 percent – occurring in the buttocks and genitalia.

Although researchers have stopped short of declaring this form of staph a sexually transmitted disease, the infections are found where skin-to-skin contact occurs during sexual activity.

Most of the infections are limited to the skin surface, but the bacteria can invade deeper tissues or disseminate through the bloodstream. According to the federal Centers for Disease Control and Prevention, various forms of MRSA are causing 95,000 of these more costly and potentially life-threatening infections – and 19,000 deaths – annually in the United States.

Until last year, staph infections had never been linked to sexual activity. Early last year, New York City physicians traced three instances of staph infection apparently spread by sexual contact. Their report was published in February in the journal Clinical Infectious Diseases.

A month later, doctors from the Albany Medical Center in New York reported in the Journal of Urology three cases of multi-drug-resistant staph in the groins of three patients – one of whom developed a form of rapid-tissue destruction popularly known as “flesh-eating bacteria” disease. The patients recovered after treatments with surgery and antibiotics.

San Francisco General Hospital physicians have been battling an aggressive strain of MRSA, called USA300, since 2001. The most recent study estimates that this strain alone is infecting about 2,000 city residents a year.

But the latest problem is being caused by a new variant of USA300 that was first detected in a San Francisco patient in 2003. Among the six antibiotics it is resistant to are three that are normally considered for treatment of suspected MRSA. The study estimated that 200 cases of this highly drug-resistant variant are turning up in San Francisco each year, mostly among gay men.

“We are nowhere near the peak,” Diep said. “The peak will occur when it spreads into the general population.”

Diep said there is reason to believe that the more drug-resistant strain will make that leap because it is just a slight variant of USA300, which became one of the most common strains of MRSA in the United States only a few years after it was first detected.

The latest study focuses on the spread of the more drug-resistant strain in San Francisco and Boston, but reports of the bug are turning up in New York and Los Angeles.

Just why the new, more drug-resistant variety is concentrated among gay men is not yet known. Patients infected with HIV appear to run a higher risk of infection, but the study suggests that gay men are being infected with the staph germ regardless of whether they are HIV-positive.

One factor that could be in play is a medical history of heavy use of antibiotics, which creates conditions for breeding drug-resistant strains. Any patient, HIV-positive or not, who has had high previous exposure to antibiotics might be more susceptible.

The good news is that, once the public is aware of the risk, there are ways to prevent the spread of drug-resistant staph. It can be as simple as soap and water.

“Taking a shower after sexual contact may minimize contamination,” said Dr. Chip Chambers, director of infectious diseases at San Francisco General, a co-author of the study. “Ordinary soap will do. It dilutes the concentration of bacteria. You don’t need antibacterial soap.”

Chambers stressed that some people, no matter how fastidious, could be more prone than others to staph infections. They could have unknown genetic traits or a history of antibiotic use that raises the risk.

“Despite one’s best efforts, it is still possible, of course, to get a staph infection,” he said. “This is why if one has a cut or open wound that it is important to clean it out and keep it clean.”

The new variant of USA300 is resistant to the antibiotics erythromycin, clindamycin, tetracycline, Cipro-like antibiotics and drugs in the penicillin family. It also does not respond to mupirocin – a gel that is often used to kill MRSA growing in people’s noses.

That still leaves a variety of antibiotics that will kill the new USA300 strain, but they tend to be more expensive and require intravenous drips. One common oral antibiotic, Bactrim, is still effective against it.

Chambers also pointed out that researchers at San Francisco General have shown that many skin sores and boils caused even by these drug-resistant strains of staph often can be treated without any antibiotics, just by surgical drainage of pus.

One of the paradoxes of bacterial infections is that using antibiotics to treat them is one of the quickest ways to promote antibiotic resistance. Although the drugs sometimes are essential, overuse is weakening their effectiveness worldwide.

Online resourcesLearn about MRSA and MRSA prevention at:links.sfgate.com/ZCBT or links.sfgate.com/ZCBQ

E-mail Sabin Russell at srussell@sfchronicle.com.

Follow

Get every new post delivered to your Inbox.

Join 28 other followers